Subcutaneous desferrioxamine: the effect of three years' treatment on liver, iron, serum ferritin, and comments on echocardiography.
D000293:Adolescent; D001206:Ascorbic Acid Deficiency / Q000209:etiology; D001219:Aspartate Aminotransferases / Q000097:blood; D002648:Child; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use*; D004452:Echocardiography; D005293:Ferritins / Q000097:blood; D006334:Heart Function Tests; D006352:Heart Ventricles / Q000033:anatomy & histology / Q000503:physiopathology; D006801:Humans; D007279:Injections, Subcutaneous; D007501:Iron / Q000378:metabolism*; D008099:Liver / Q000187:drug effects*; D008134:Long-Term Care; D013789:Thalassemia / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D065227:Transfusion Reaction
D005293:Ferritins; D007501:Iron; D001219:Aspartate Aminotransferases; D003676:Deferoxamine